Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

Questions surrounding Indian CRO result in medicine suspension recommendation

22-Jul-2016 - The EMA is recommending the suspension of several medicines after inspections revealed flawed studies at the India-based contract research organization (CRO), Semler Research Centre.

Mitsubishi Tanabe licenses simulation tech

21-Jul-2016 - Mitsubishi Tanabe has joined the Simcyp Consortium – gaining a license to the modeling and simulation group’s pharmacokinetic prediction technology.

Exco InTouch approved fully compliant with NIST guidelines

20-Jul-2016 - Exco InTouch has completed a HIPAA Privacy audit as the company continues to prepare for impending data protection regulations.

Envigo facilities earn AAALAC accreditation

20-Jul-2016 - Envigo has announced that its sites in Bresso, Italy and Wyton, UK have earned their accreditation from the lab animal treatment watchdog, AAALAC.

NCI: global initiative to create 1,000 cancer cell models

18-Jul-2016 - A newly-launched international project seeks to develop a new bank of cancer cell culture models for the research community.

FDA issues draft guidances on next gen sequencing

14-Jul-2016 - The FDA has issued two new guidances as part of the President’s Precision Medicine Initiative.

CrownBio introduces new recombinant cell lines for oncology drug discovery

11-Jul-2016 - CrownBio’s new stable cell lines feature various immune checkpoints and receptors which are key targets and pathways for oncology drug discovery and development.

Exclusive interview

NIH Deputy Director: manufactured stem cells to advance clinical research

29-Jun-2016 - Researchers supported by the National Institutes of Health (NIH) have developed a clinical-grade stem cell line, which will help accelerate early-stage clinical research.

CrownBio expands immuno-oncology offerings

16-Jun-2016 - Crown Bioscience has expanded its immuno-oncology platform at its facilities in Europe, the US, and Asia to include immunophenotyping analysis.

Dispatches from BIO 2016

Drug development in space: how microgravity enables pharma

15-Jun-2016 - Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.

AMRI to provide services for drug development consortium

15-Jun-2016 - As a dedicated Chemical Biology Consortium center, AMRI will provide a variety of drug discovery services to help advance early stage drug discovery projects.

WuXi AppTec adopts Elsevier tech, gains access to 500m experimental details

13-Jun-2016 - WuXi AppTec has adopted Elsevier’s technology as the company begins to focus less on point solutions, and more on provider partnerships, says VP of procurement.

Bridging the 'cultural gap in drug development' with Silicon-Valley technology

02-Jun-2016 - Sensors, computer vision, machine learning, and cloud computing are enabling preclinical researchers to conduct higher quality studies in a shorter period of time. 

Exclusion lists challenging drug developers

01-Jun-2016 - Rising drug prices and the subsequent increasing number of drugs ineligible for reimbursement will challenge drug developers to provide clinical superiority evidence.

Biomarkers triple clinical trial success rate, says report

26-May-2016 - A recent study of clinical drug development success rates found that biomarker-enabled drug programs are three times more likely to reach approval.

Exclusive interview

Charles River mulls moonshots and mouse models

24-May-2016 - Charles River Laboratories is conducting new studies using animal models to give insight into therapeutic strategies where pharma companies expect to see the most success.

Genentech extends Evotec small molecule discovery contract

24-May-2016 - German discovery services firm Evotec has had its contract with Genentech extended for a second time

Crown Bioscience launches high throughput service platform

23-May-2016 - Crown Bioscience has launched an oncology service platform to improve preclinical studies using patient-derived xenograft (PDX) models.

Preclinical outsourcing to grow 20% in 2016 says new report

17-May-2016 - More drug discovery work will be outsourced this year according to a report which suggests pharmaceutical industry desire to reduce the risk of failure and cut costs persists.

Microbiome research tool developed for drug development

16-May-2016 - Researchers have developed an organ-on-a-chip model that will allow for preclinical testing in an environment analogous to the human gastrointestinal tract.

New mouse model, new opportunities for Zika research

12-May-2016 - Researchers have developed a new mouse model that allows them to ask different questions about the effects of the Zika virus.

Mass Innovation Labs: the evolution of R&D

05-May-2016 - Mass Innovation Labs is working to change the way biopharmaceutical companies conduct research by providing a “crossroads” for CRO service providers, vendors, and investors.

Elsevier’s ‘Hive Project’ to promote drug discovery

02-May-2016 - As a significant amount of drug discoveries occur outside of pharma companies, Elsevier has launched The Hive Project to promote innovation in the market – outside its walls.

‘Dirty mice’ better mirror humans, says researcher

25-Apr-2016 - Mice are used to model various human diseases – yet the animals don’t replicate some significant features of the adult human immune system.

Stem cells form tiny beating heart for drug testing

22-Apr-2016 - While there are currently several techniques for producing tissue from heart cells, a new method reduces the amount of cells needed, making it easier and cheaper to replicate.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...